Albion Financial Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,368	Closed	-$253K	–	627
2024 Q4	$253K	Buy	1,368 +24	+2%	+$4.62K	0.02%	172
2024 Q3	$265K	Buy	1,344 +1	+0.1%	+$208	0.02%	163
2024 Q2	$277K	Sell	1,343 -55	-4%	-$12.5K	0.02%	168
2024 Q1	$379K	Hold	1,398	–	–	0.03%	149
2023 Q4	$330K	Hold	1,398	–	–	0.03%	153
2023 Q3	$274K	Buy	1,398 +120	+9%	+$24.6K	0.03%	152
2023 Q2	$269K	Sell	1,278 -50	-4%	-$9.95K	0.02%	160
2023 Q1	$268K	Buy	1,328 +107	+9%	+$24.2K	0.02%	155
2022 Q4	$266K	Sell	1,221 -10	-0.8%	-$2.18K	0.03%	154
2022 Q3	$242K	Buy	1,231 +78	+7%	+$16.8K	0.03%	156
2022 Q2	$247K	Sell	1,153 -220	-16%	-$53.8K	0.02%	159
2022 Q1	$390K	Buy	1,373 +7	+0.5%	+$2.16K	0.03%	164
2021 Q4	$515K	Sell	1,366 -39	-3%	-$15.2K	0.04%	158
2021 Q3	$580K	Hold	1,405	–	–	0.05%	144
2021 Q2	$520K	Buy	+1,405	New	+$469K	0.05%	147
2020 Q4	$347K	Buy	1,390 +185	+15%	+$44.1K	0.03%	157
2020 Q3	$273K	Buy	+1,205	New	+$250K	0.03%	188